Insurance for Biotechs: Property 2741009234941582512-blid-2506662077544058718

ปักหลักสิบล่างแม่นจริงสูตรนี้ 8งวดติด 2พฤษภาคม2562

Biotechnology companies and organisations display distinctive features and, from an insurance perspective, uncommon risks. Quite apart from liability risks associated with the testing of investigational drugs, biotech companies are faced with some unique exposures that could delay development, and possibly, the achievement of milestones. Such delays could hamper the ability of the company to raise additional funds and therefore its ability to continue as a going concern.